Hospital CEO tells Juneau finance committee 340B outpatient expansion is feasible but complex and years away

The Finance Committee heard a detailed briefing May 6 about what the packet described as the "3 40 b" hospital drug‑pricing program and what it would take for Bartlett to secure outpatient drug pricing benefits.

Bartlett’s chief executive (identified in the transcript as Mister Warner) told the committee: "This is a super complex process that is heavily, heavily regulated. And so HRSA does audits on these programs on an annual basis, and they'll come in and they'll go down to the patient level. You have to have contracts in place. So a lot of this work isn't gonna be done with on‑site talent that we have today." He said hospital staff would likely need specialist contractors to set up systems, contracts and compliance processes and estimated a conservative two‑year timeline to stand up outpatient pharmacy operations and associated contract structures.

Staff and committee members questioned whether benefits from contract pharmacies would accrue to Bartlett or to the broader City and Borough (CBJ) health plan. Deputy Manager Barr summarized staff understanding: under a contract‑pharmacy model Bartlett would benefit directly from the pricing discounts; only once Bartlett had an on‑site pharmacy run by Bartlett employees could the hospital engage the health‑plan administrator so benefits flowed to the wider CBJ health plan. "If the hospital has ... an on‑site pharmacy that is run by its own employed [staff], then the hospital could engage in a contractual process with our, health plan administrator, to such that the benefits could go to the health plan," Barr said.

Committee members asked about interim options. Warner and staff confirmed that interim contract pharmacy arrangements with external pharmacies are possible, and that the hospital could benefit first under such models while pursuing a permanent on‑site pharmacy. Warner said he could not give a precise startup cost and cautioned that internal renovations would likely be more expensive than an external location, but that operational steps and contracting were the critical path.

Why it matters: committee members are weighing near‑term FY27 budget changes and long‑term policy options related to the hospital as an enterprise affecting city health plan costs and potential offsets to city contributions. If Bartlett can stand up outpatient pharmacy services that qualify for 340B‑like pricing, it could reduce drug expense pressure on the hospital and (with further policy choices) potentially on the CBJ health plan.

Next steps: the committee thanked Warner for his presentation and will track the hospital's steps should the assembly wish to provide additional direction; no formal vote on implementation or funding for construction was taken.